Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors

Acta Oncologica
Line V HjelleHege S Haugnes

Abstract

The long-term toxicities after cisplatin-based chemotherapy (CBCT) reveal a remarkable inter-individual variation among testicular cancer survivors (TCSs). Therefore, we assessed long-term platinum (Pt) changes and their associations with CBCT-related late effects in TCSs. In 77 TCSs treated with CBCT from 1984 to 1990, blood samples for analyses of Pt and a questionnaire including self-reported neuro- and ototoxicity (NTX) symptoms were collected during two follow-up surveys at median 12 (Survey I; SI) and 20 (Survey II; SII) years after treatment. Information about second cancers after SII was retrieved from the Norwegian Cancer Registry. A larger Pt decline from SI to SII was associated with a decreased risk of a second cancer diagnosis (HR 0.78, 95% CI 0.62-0.99 per 10 ng/L/year), and worsening of paresthesias in hands (OR 1.98, 95% CI 1.09-3.59 per 10 ng/L/year) and tinnitus (OR 1.51, 95% CI 1.01-2.27 per 10 ng/L/year). In summary, we found a significant association between a larger Pt decline and a reduced risk of second cancers and deterioration of paresthesias in hands and tinnitus.

References

Aug 11, 1979·Lancet·M J PeckhamW F Hendry
Sep 1, 1985·Cancer Treatment Reviews·R F OzolsR C Young
Jan 1, 1995·Cancer Chemotherapy and Pharmacology·R SchierlJ Hohnloser
Jan 21, 1995·BMJ : British Medical Journal·J M Bland, D G Altman
Apr 12, 2001·Journal of Clinical Epidemiology·R Bender, S Lange
May 16, 2001·Environmental Science & Technology·C BarbanteC Boutron
May 24, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L ThorsenS D Fosså
Sep 22, 2005·Journal of the National Cancer Institute·Lois B TravisEthel S Gilbert
May 25, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Jan OldenburgAlv A Dahl
Dec 22, 2006·American Journal of Epidemiology·Eric Vittinghoff, Charles E McCulloch
Jan 18, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan OldenburgSophie D Fossa
Sep 18, 2008·BMC Clinical Pharmacology·Elke E M BrouwersJan H M Schellens
Apr 17, 2010·European Urology·Marianne BrydøyUNKNOWN Norwegian Urology Cancer Group III study group
Nov 23, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BosettiC La Vecchia
Dec 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mette SprautenLois B Travis
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hege S HaugnesSophie D Fosså
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chunkit FungLois B Travis
May 9, 2014·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Justyna PawlakJakub Chrustowicz
Nov 2, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J LauritsenG Daugaard
Sep 9, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H BoerJ A Gietema
Nov 23, 2017·Nature Communications·Andrew M BreglioLisa L Cunningham
Jan 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J LauritsenG Daugaard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.